FY2026 EPS Estimates for Sandoz Group Increased by Analyst

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) – Investment analysts at Erste Group Bank increased their FY2026 earnings estimates for Sandoz Group in a research note issued to investors on Friday, September 18th. Erste Group Bank analyst H. Engel now expects that the company will post earnings of $4.20 per share for the year, up from their prior forecast of $4.13. Erste Group Bank has a “Strong-Buy” rating on the stock. The consensus estimate for Sandoz Group’s current full-year earnings is $4.12 per share. Erste Group Bank also issued estimates for Sandoz Group’s FY2027 earnings at $4.60 EPS.

Sandoz Group Price Performance

Sandoz Group stock opened at $84.91 on Tuesday. The company’s 50-day moving average price is $84.46 and its two-hundred day moving average price is $83.42. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.18 and a quick ratio of 0.77. Sandoz Group has a twelve month low of $55.42 and a twelve month high of $94.15.

About Sandoz Group

Sandoz Group AG is a Switzerland-based pharmaceutical company focused on developing, manufacturing and supplying generic and biosimilar medicines. Its portfolio includes products across areas such as anti-infectives, immunology, oncology, ophthalmology, respiratory care and cardiovascular medicine, as well as injectable and specialty pharmaceuticals.

The company traces its origins to Sandoz, founded in Basel in 1886, and became an independent business through its separation from Novartis in 2023.